Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

196
Delayed Quote. Delayed London Stock Exchange - 03/31 11:35:22 am
1546 GBp   -2.43%
03/30 J&J, Glaxo settle U.S. lawsuit over allergy ads
03/30 Glaxo Reaches Agreement With UK Government For Meningitis B Vacci..
03/29 GLAXOSMITHKLINE : Britain to offer all infants meningitis B vaccine
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline: European Commission Authorizes Nimenix

04/27/2012 | 08:24am US/Eastern

GlaxoSmithKline PLC (>> GlaxoSmithKline plc), the drug company, said Friday that the European Commission has granted marketing authorization for Nimenrix, Meningococcal group A, C, W-135 and Y conjugate vaccine, for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y.

-Shares at 1207 GMT, up a penny, or 0.04%, at 1,420.5 pence valuing the company at GBP71.61 billion.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
React to this article
Latest news on GLAXOSMITHKLINE PLC
02:05p GLAXOSMITHKLINE : Zofran Lawsuit Information Page Launched In Response To Client..
01:41a GLAXOSMITHKLINE : Robert Gardner Law Announces Resource Site for Patients Prescr..
03/30 J&J, Glaxo settle U.S. lawsuit over allergy ads
03/30 Glaxo Reaches Agreement With UK Government For Meningitis B Vaccine
03/30 GLAXOSMITHKLINE : Meningitis vaccine deal
03/29 GLAXOSMITHKLINE : Britain to offer all infants meningitis B vaccine
03/29 GLAXOSMITHKLINE : UK Department of Health Reports on 2 Proposed Ebola Vaccines
03/28 GLAXOSMITHKLINE : GSK statement on meningitis vaccination in the UK
03/27 GLAXOSMITHKLINE : The Law Office of Melinda J. Helbock, A.P.C. Announces That It..
03/27 GLAXOSMITHKLINE : GSK receives approval for Encruse Ellipta in Japan for the tre..
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF